$CPRT

What to Expect From Copart's Next Quarterly Earnings Report

Copart (CPRT) is set to report fiscal Q4 2026 results soon. Analysts expect EPS of $0.39, down from $0.41 a year ago, and forecast $1.58 EPS for fiscal 2026. After Q3 results, shares fell 1.8% as insurance auction volumes weakened. The average price target is $42.73.

Original reporting
Published Jul 28, 2026, 11:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 11:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
What to Expect From Copart's Next Quarterly Earnings Report — source image
Decision brief

The 30-second read

$CPRTNeutralLow
01

Why it matters

The preview frames the upcoming earnings around weaker insurance auction volumes, softer claims activity, and higher logistics/facility operating expenses, with consensus EPS expected to decline year over year.

02

Market read

Provides consensus EPS expectations and the specific operational pressure points likely to be scrutinized in the upcoming print.

03

What to watch

The article notes no formal guidance and highlights a large U.S. noninsurance TAM; traders may focus on noninsurance mix and logistics efficiency rather than insurance volumes alone.

Relevance 4/10Novelty 3/10Timing: Ahead of Copart’s next quarterly earnings release (fiscal Q4 2026).

Background

Copart runs online vehicle auctions across 250+ locations in 11 countries and is expected to report fiscal Q4 2026 results soon.

Company-level read

Ticker impact

$CPRTNeutralMedium confidence
Context

Article previews Copart’s upcoming fiscal Q4 2026 results, citing consensus EPS $0.39 and key volume and cost pressures.

Expected impact

Moderate two-sided reaction risk around the Q4 print depending on whether insurance volumes and operating expense trends stabilize.

Evidence & confidence

The text provides consensus EPS and specific drivers (insurance unit declines, logistics cost increase, no formal revenue/EPS guidance), but it does not include a new company disclosure beyond expectations.

Market effects

Could signal demand sensitivity in vehicle remarketing tied to insurance coverage and claims activity, relevant to auto-remarketing and salvage-adjacent names.

No specific regional catalyst beyond mention of Middle Eastern buyer participation and international unit growth.

Limited; discussion is company-specific with only broad cross-border volume and logistics cost context.

Counterpoint

If insurance auction volumes are already bottoming and international growth offsets U.S. softness, the stock could outperform consensus despite the bearish volume narrative.

Key entities

  • Copart, Inc.

    Subject of the earnings preview, with consensus EPS and recent Q3 volume/cost drivers discussed.

Related articles

$CPRTHighAI 9/10

Copart Q3 Earnings Call Highlights

Copart reported fiscal Q3 2026 revenue up 2.1% to $1.24B and net income of $402.4M, with diluted EPS up 2.4% to $0.43, according to its earnings call. Insurance unit volumes fell 2.7% globally (4.2% in the U.S.). Management cited higher average selling prices (+4.6%) and gross margin rising 71 bps to 46.3%.

$KDMed

Kyndryl Q1 Earnings Call Highlights

Kyndryl (NYSE:KD) Q1 call said demand is rising for AI deployment, hybrid modernization, cybersecurity and data-residency. It reported 40 deals worth over $50M in 12 months, with 10 in Q1, and Kyndryl Consult signings up 50%. IBM relationship changes are expected to weigh on constant-currency revenue through FY2027. FCF was -$401M; cash $2.1B. Outlook FY2027 reaffirmed.

$KAIMedAI 8/10

Kadant Q2 Earnings Call Highlights

Kadant (NYSE:KAI) reported Q2 equipment backlog of $182 million and said aftermarket demand stayed at record or near-record levels. Flow Control revenue rose 5% to $100 million; Industrial Processing revenue rose to a record $144 million; Material Handling bookings were $73 million. Q2 gross margin fell to 43.8%. Kadant raised FY revenue guidance to $1.19-$1.21B and adjusted EPS to $12.43-$12.68.

$KRPMed

Kimbell Royalty Q2 Earnings Call Highlights

Kimbell Royalty (NYSE:KRP) reported record Q2 adjusted EBITDA of $84.9 million, with cash G&A of $5.9 million ($2.50 per BOE). It declared a $0.47 per common unit cash distribution, up 15% QoQ, and said 47% may be return of capital. The borrowing base rose to $660 million; debt was $478.7 million. Rig activity and production varied by basin.

$KMPRMed

Kemper Q2 Earnings Call Highlights

Kemper (NYSE:KMPR) reported Q2 results and discussed credit-loss allowances tied to surplus notes in its reciprocal exchange, including a $21 million pre-tax charge on $36 million of notes. Holding-company liquidity was $766 million and debt-to-capital rose to 28.3%. Personal auto normalized combined ratio was 102% and commercial 93.7%, with California rate actions and restructuring savings over $80 million run-rate.

$KOPMed

Koppers Q2 Earnings Call Highlights

Koppers (NYSE:KOP) reported Q2 updates on capital spending of about $24M, shareholder returns of $47M, and debt reduction of $22M in the first half. Liquidity was $390M with net debt of $857M and net leverage at 3.5x. The board raised its dividend to $0.09/share. KOP kept 2026 sales guidance at $1.9B-$2.0B but cut adjusted EBITDA to $240M-$250M and EPS to $3.80-$4.20.